Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | KDM1A | O60341 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18355019 | 0.87 | LMNA (0.45) | SMN1; SMN2ALDH1A1NPC1RAB9AMAPT | |
| SCHEMBL18354253 | 0.82 | NPC1 (0.49) | SMN1; SMN2ALDH1A1MEN1GAAKMT2A | |
| SCHEMBL18360529 | 0.81 | RAB9A (0.54) | SMN1; SMN2ALDH1A1MEN1GAAALOX15 | |
| SCHEMBL18354547 | 0.80 | NPC1 (0.57) | SMN1; SMN2KDM1AALDH1A1MEN1GAA | |
| SCHEMBL18360500 | 0.78 | KDM4E (0.55) | SMN1; SMN2ALDH1A1MEN1ALOX15TSHR | |
| SCHEMBL18355017 | 0.76 | KMT2A (0.51) | SMN1; SMN2ALDH1A1MEN1GAAKMT2A | |
| SCHEMBL18355014 | 0.76 | KDM4E (0.41) | SMN1; SMN2KDM1AALDH1A1MEN1GAA | |
| SCHEMBL18354248 | 0.76 | PPARG (0.46) | SMN1; SMN2ALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL18354114 | 0.75 | CA1 (0.38) | KMT2AMAPT | |
| SCHEMBL18354525 | 0.72 | CA1 (0.49) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (SE) | 2017-01-05 | — | — | US | disclosed |
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (SE) | 2017-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | CYP4X1, BROX, CYP1B1 | SMN1; SMN2 2375/4885KDM1A 451/4885ALDH1A1 1143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.